Komipharm International Australia
Komipharm have long been interested in oncology treatments and drug development dating back to 1980. Over the years they have focused on oral anti-cancer and pain-relieving therapies to develop effective medicines.
Komipharm has been working with many leading international experts on the R&D for its drugs and is quickly emerging as global leader in the development of effective cancer pain management medication.
Komipharm Australia is part of a leading Korean producer of drugs for human and veterinary use, Komipharm International Australia Pty Ltd plans to design and build one of the largest pharmaceutical (high – potency) tablet manufacturing facilities in the world in Dandenong South, estimated investment is $40m. This state of the art manufacturing facility will be highly automated, incorporating Industry 4.0 technology and Lean thinking as fundamental elements in the facility design.